-- 本周，美国股市指数上涨，原因是以色列袭击黎巴嫩和霍尔木兹海峡后，伊朗和平谈判仍按计划进行，且3月份公布的通胀报告符合预期。 * 标普500指数周五收于6816.89点，高于一周前的6582.69点。纳斯达克综合指数约为22902.89点，高于一周前的21829.18点。道琼斯工业平均指数收于47916.57点，高于上周末的46504.67点。 * 本周，工业、通信服务和周期性消费板块领涨，能源板块是唯一下跌的板块。由于美伊停火协议包括重新开放霍尔木兹海峡（全球约五分之一原油运输的咽喉要道），地缘政治风险有所缓解。 * 据《华尔街日报》报道，在周三的空袭造成超过250人死亡、数百人受伤，并威胁到停火协议后，美国总统唐纳德·特朗普要求以色列总理本雅明·内塔尼亚胡减少对黎巴嫩的袭击。 * 和平谈判定于周六在伊斯兰堡举行。此前，美国、以色列和伊朗在会前夕提出了威胁和先决条件，其中包括改善霍尔木兹海峡的海上交通。副总统约翰·迪·万斯将率领一个美国谈判团队参加谈判，团队成员包括特朗普的特使史蒂夫·威特科夫和女婿贾里德·库什纳。 * 据《华尔街日报》报道，万斯在前往参加这场至关重要的谈判之前表示，华盛顿“愿意在本周末的谈判中伸出橄榄枝”，但警告德黑兰不要“试图耍我们”。 * 在经济数据方面，投资者主要关注通胀数据。 2月份个人消费支出价格指数基本符合预期，但并未反映出伊朗战争对原油价格的影响。正如预期，3月份消费者价格指数上涨0.9%，并加速至近四年来的最高月度水平，原因是中东冲突导致能源价格大幅上涨。
Related Articles
Insider Trading
Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing
Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml
$LFST
Australia
Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set
Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.
$CLS
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.
$AMP